These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37777714)

  • 1. Predicting tumour content of liquid biopsies from cell-free DNA.
    Cardner M; Marass F; Gedvilaite E; Yang JL; Tsui DWY; Beerenwinkel N
    BMC Bioinformatics; 2023 Sep; 24(1):368. PubMed ID: 37777714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidimensional fragmentomic profiling of cell-free DNA released from patient-derived organoids.
    Kim J; Hong SP; Lee S; Lee W; Lee D; Kim R; Park YJ; Moon S; Park K; Cha B; Kim JI
    Hum Genomics; 2023 Oct; 17(1):96. PubMed ID: 37898819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis.
    Moldovan N; van der Pol Y; van den Ende T; Boers D; Verkuijlen S; Creemers A; Ramaker J; Vu T; Bootsma S; Lenos KJ; Vermeulen L; Fransen MF; Pegtel M; Bahce I; van Laarhoven H; Mouliere F
    Cell Rep Med; 2024 Jan; 5(1):101349. PubMed ID: 38128532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood has never been thicker: Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomas.
    Meriranta L; Pitkänen E; Leppä S
    Semin Hematol; 2023 Jul; 60(3):132-141. PubMed ID: 37455222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic biases in reference-based plasma cell-free DNA fragmentomic profiling.
    Liu X; Yang M; Hu D; An Y; Wang W; Lin H; Pan Y; Ju J; Sun K
    Cell Rep Methods; 2024 Jun; 4(6):100793. PubMed ID: 38866008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples.
    Van Paemel R; Vandeputte C; Raman L; Van Thorre J; Willems L; Van Dorpe J; Van Der Linden M; De Wilde J; De Koker A; Menten B; Devalck C; Vicha A; Grega M; Schleiermacher G; Iddir Y; Chicard M; van Zogchel L; Stutterheim J; Lak NSM; Tytgat GAM; Laureys G; Speleman F; De Wilde B; Lammens T; De Preter K; Van Roy N
    Eur J Cancer; 2022 Jan; 160():12-23. PubMed ID: 34794856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsies: DNA methylation analyses in circulating cell-free DNA.
    Zeng H; He B; Yi C; Peng J
    J Genet Genomics; 2018 Apr; 45(4):185-192. PubMed ID: 29706556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review.
    Cervena K; Vodicka P; Vymetalkova V
    Mutat Res Rev Mutat Res; 2019; 781():100-129. PubMed ID: 31416571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Preanalytical and Physiological Variables on Cell-Free DNA Fragmentation.
    van der Pol Y; Moldovan N; Verkuijlen S; Ramaker J; Boers D; Onstenk W; de Rooij J; Bahce I; Pegtel DM; Mouliere F
    Clin Chem; 2022 Jun; 68(6):803-813. PubMed ID: 35292813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies.
    Jiang P; Chan KCA; Lo YMD
    J Hepatol; 2019 Aug; 71(2):409-421. PubMed ID: 31004682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When Tissue Is the Issue: Expanding Cell-Free DNA "Liquid Biopsies" to Supernatants and Nonplasma Biofluids.
    Paulson V; Konnick EQ; Lockwood CH
    Clin Lab Med; 2022 Sep; 42(3):485-496. PubMed ID: 36150825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencing.
    van der Pol Y; Tantyo NA; Evander N; Hentschel AE; Wever BM; Ramaker J; Bootsma S; Fransen MF; Lenos KJ; Vermeulen L; Schneiders FL; Bahce I; Nieuwenhuijzen JA; Steenbergen RD; Pegtel DM; Moldovan N; Mouliere F
    EMBO Mol Med; 2023 Dec; 15(12):e17282. PubMed ID: 37942753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidimensional Fragmentomics Enables Early and Accurate Detection of Colorectal Cancer.
    Cao Y; Wang N; Wu X; Tang W; Bao H; Si C; Shao P; Li D; Zhou X; Zhu D; Yang S; Wang F; Su G; Wang K; Wang Q; Zhang Y; Wang Q; Yu D; Jiang Q; Bao J; Yang L
    Cancer Res; 2024 Oct; 84(19):3286-3295. PubMed ID: 39073362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of Cell-Free DNA End Motifs and Fragment Lengths Can Identify Active Genes in Liquid Biopsies.
    Maansson CT; Thomsen LS; Meldgaard P; Nielsen AL; Sorensen BS
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
    Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
    Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat inactivation does not alter host plasma cell-free DNA characteristics in infectious disease research.
    Luo Y; Zhang H; Li L; Lin Y; Wang X; Chen W; Tao Y; Ou R; Zhou W; Zheng F; Jin Y; Cheng F; Zhu H; Zhang Y; Jin X
    Clin Chim Acta; 2024 Jan; 553():117751. PubMed ID: 38163539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep cfDNA fragment end profiling enables cancer detection.
    Zhitnyuk YV; Koval AP; Alferov AA; Shtykova YA; Mamedov IZ; Kushlinskii NE; Chudakov DM; Shcherbo DS
    Mol Cancer; 2022 Jan; 21(1):26. PubMed ID: 35062943
    [No Abstract]   [Full Text] [Related]  

  • 18. Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics.
    Song P; Wu LR; Yan YH; Zhang JX; Chu T; Kwong LN; Patel AA; Zhang DY
    Nat Biomed Eng; 2022 Mar; 6(3):232-245. PubMed ID: 35102279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology.
    Ponti G; Manfredini M; Tomasi A
    Crit Rev Oncol Hematol; 2019 Sep; 141():36-42. PubMed ID: 31212145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patients.
    Mouliere F; Smith CG; Heider K; Su J; van der Pol Y; Thompson M; Morris J; Wan JCM; Chandrananda D; Hadfield J; Grzelak M; Hudecova I; Couturier DL; Cooper W; Zhao H; Gale D; Eldridge M; Watts C; Brindle K; Rosenfeld N; Mair R
    EMBO Mol Med; 2021 Aug; 13(8):e12881. PubMed ID: 34291583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.